EUpolicy

News

Sanofi escapes fine in EU mismarketing case

Sanofi will not be fined for disparaging an influenza vaccine sold by rival CSL in a marketing campaign, according to the European Commission.

Market Access

Magnifying glass over pills scattered over dollar and euro notes

One year after MFN: How US policy is reshaping the global ph...

Just over a year has passed since the Trump administration sent letters to 17 leading manufacturers demanding steps towards MFN pricing.

Market Access

Beyond Market Access: Why healthcare-system understanding is...

Healthcare-system literacy, and the ability to contribute to system shaping, must become part of how healthcare leaders make decisions.

News

Pharma leaders urge Europe to halt 'slow agony' of decline

Europe's top pharma firms have called on governments to take action to change the region's story from one of decay to one of "renewal and resilience."

Market Access

pharmaphorum podcast Episode 275, Giancarlo Benelli, BeOne Medicines

Europe for life sciences and for patients, with BeOne Medici...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Giancarlo Benelli, SVP & Head of Europe at BeOne Medicines.

Market Access

The EU Joint Clinical Assessment in practice: Early lessons

Unfortunately, much of the discussion around the JCA has focused on how the framework is intended to operate, rather than how it works in practice.

Sanofi escapes fine in EU mismarketing case

One year after MFN: How US policy is reshaping the global ph...

Beyond Market Access: Why healthcare-system understanding is...

Pharma leaders urge Europe to halt 'slow agony' of decline

Europe for life sciences and for patients, with BeOne Medici...

The EU Joint Clinical Assessment in practice: Early lessons

RNAi biotech City hauls in $200m in upsized IPO

Discover a new era of healthcare panel engagement: Grounded ...

EUpolicy

Editor's Picks